8885051

Giudice LC

1996

Growth factors and polycystic ovarian syndrome.

8886620

Peng X

1996

Comparison of immunocytologic localization of insulin-like growth factor binding protein-4 in normal and polycystic ovary syndrome human ovaries.

8887000

Singh KB

1996

Hormonal modulation of the vaginal bacterial flora in experimental polycystic ovarian disease.

8887188

Elkind-Hirsch KE

1996

Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.

8888256

Kimura I

1996

Polycystic ovaries: implications of diagnosis with MR imaging.

8890725

Fiad TM

1996

Role of progesterone deficiency in the development of luteinizing hormone and androgen abnormalities in polycystic ovary syndrome.

8891527

Niccoli P

1996

Interest of epitopic dissection in immunoanalysis of proteins and peptides: review of theoretical and practical aspects.

8893680

Aboulghar MA

1996

Recombinant follicle-stimulating hormone in the treatment of patients with history of severe ovarian hyperstimulation syndrome.

8893705

Campagnoli C

1996

Misplaced confidences?

8894317

Olatunbosun OA

1996

Spontaneous ovarian hyperstimulation syndrome in four consecutive pregnancies.

8908525

G?kmen O

1996

Comparison of four different treatment regimes in hirsutism related to polycystic ovary syndrome.

8908526

Liguori G

1996

Laparoscopic ovarian treatment in infertile patients with polycystic ovarian syndrome (PCOS): endocrine changes and clinical outcome.

8908619

Navarra P

1996

Increased production and release of prostaglandin-E2 by human granulosa cells from polycystic ovaries.

8915660

von Eckardstein S

1996

Elevated low-density lipoprotein-cholesterol in women with polycystic ovary syndrome.

8915661

Falsetti L

1996

Hyperinsulinemia in the polycystic ovary syndrome: a clinical, endocrine and echographic study in 240 patients.

8915662

Schachter M

1996

Hypogonadotropic patients with ultrasonographically detected polycystic ovaries: endocrine response to pulsatile gonadotropin-releasing hormone.

8915663

Grisaru D

1996

A case of severe hyperandrogenism, acanthosis nigricans and over diabetes: the use of non-invasive methods for diagnosis, pathogenesis and management.

8915666

Jahanfar S

1996

Genetic and non-genetic theories on the etiology of polycystic ovary syndrome.

8921052

Meirow D

1996

Dyslipidaemia in polycystic ovarian syndrome: different groups, different aetiologies?

8923819

White DM

1996

Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women.

8923867

Iba?ez L

1996

Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.

8923878

Brzechffa PR

1996

Serum immunoreactive leptin concentrations in women with polycystic ovary syndrome.

8923880

Gharani N

1996

5' polymorphism of the CYP17 gene is not associated with serum testosterone levels in women with polycystic ovaries.

8932921

Kaaks R

1996

Nutrition, hormones, and breast cancer: is insulin the missing link?

8933191

Hara M

1996

Acromegaly associated with Chiari-I malformation and polycystic ovary syndrome.

8936907

Garland EJ

1996

Hormonal effects of valproic acid?

8941059

Norman RJ

1996

Hyperinsulinemia is common in family members of women with polycystic ovary syndrome.

8943510

Andreani CL

1996

Effect of follicular fluid on granulosa luteal cells from polycystic ovary.

8949487

Bercovici JP

1996

[Polycystic ovary and diazoxide. In vivo study].

8949885

Ruiz A

1996

RU486-treated rats show endocrine and morphological responses to therapies analogous to responses of women with polycystic ovary syndrome treated with similar therapies.

8959075

Mici? D

1996

Growth hormone response to GHRH, GHRP-6 and GHRH + GHRP-6 in patients with polycystic ovary syndrome.

8966389

Espinosa de los Monteros A

1996

[Androgen response in women with polycystic ovary syndrome and hyperinsulinemia during stimulation with corticotrophin and inhibition with dexamethasone].

8969938

Reincke M

1996

Adrenal incidentalomas: a manifestation of the metabolic syndrome?

8977757

Piaditis GP

1996

The effect of sequential administration of octreotide alone and octreotide/growth hormone simultaneously on buserelin stimulated ovarian steroid secretion in women with polycystic ovary syndrome.

8977761

Sampson M

1996

Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome.

8981115

Lanzone A

1996

Preconceptional and gestational evaluation of insulin secretion in patients with polycystic ovary syndrome.

8981120

Anttila L

1996

Normal serum uric acid concentrations in women with polycystic ovary syndrome.

8981129

Nawroth F

1996

Severe ovarian hyperstimulation syndrome (OHSS) and icterus.

8981147

Cameron ST

1996

Effects of daily low dose mifepristone on endometrial maturation and proliferation.

8986680

Lanzone A

1997

Somatostatin treatment reduces the exaggerated response of adrenocorticotropin hormone and cortisol to corticotropin-releasing hormone in polycystic ovary syndrome.

8988526

Kettel LM

1996

Ovulation induction in the estrogenized anovulatory patient.

8991586

Pauthier S

1996

[Role of surgery in the treatment of infertility due to polycystic ovaries].

8992921

Birdsall MA

1997

Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization.

8993065

Braverman PK

1997

Menstrual disorders.

9000866

Sakiyama R

1996

Approach to patients with hirsutism.

9000867

Agarwal SK

1996

What we see most, we understand least.

9002393

Kopala LC

1997

Clinical features of schizophrenia in a woman with hyperandrogenism.

9003026

Zachow RJ

1997

Direct intraovarian effects of leptin: impairment of the synergistic action of insulin-like growth factor-I on follicle-stimulating hormone-dependent estradiol-17 beta production by rat ovarian granulosa cells.

9003093

Fi?icio?lu C

1996

The number of follicles and ovarian volume in the assessment of response to clomiphene citrate treatment in polycystic ovarian syndrome.

9004535

Anderson E

1996

The effects of dehydroepiandrosterone (DHEA) and its metabolites on the polycystic ovarian condition (PCO): cystogenic changes of rat granulosa cells in vitro.

9005385

Kolosz?r S

1996

[Ovulation induction with adjuvant antiandrogen treatment in Stein-Leventhal syndrome].

9006845

Fox R

1996

Macrofolliculoid granulosa cell tumour mistaken for a polycystic ovary at ultrasound scan.

9011736

Aganovi? I

1996

[National consensus on hyperandrogenemia].

9013299

Tarlatzis BC

1997

The significance of high follicular-phase luteinizing hormone levels in the treatment of women with polycystic ovarian syndrome by in vitro fertilization.

9013300

Artini PG

1997

Clinical utility of adjuvant growth hormone in the treatment of patients with polycystic ovaries undergoing in vitro fertilization.

9013301

Shulman A

1997

In vitro fertilization treatment in patients with polycystic ovaries.

9013302

Barri PN

1997

Treatment of polycystic ovary patients undergoing IVF.

9013303

Franks S

1997

The treatment of patients with polycystic ovaries undergoing IVF.

9021354

Hugues JN

1996

Sequential step-up and step-down dose regimen: an alternative method for ovulation induction with follicle-stimulating hormone in polycystic ovarian syndrome.

9022621

Arnhold IJ

1997

Ovarian resistance to luteinizing hormone: a novel cause of amenorrhea and infertility.

9024248

Ehrmann DA

1997

Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome.

9024253

Jakubowicz DJ

1997

17 alpha-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss.

9024269

Fulghesu AM

1997

The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome.

9028359

Anderson KE

1997

Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa.

9032568

Morris DV

1996

The relationship between insulin sensitivity and insulin-like growth factor-binding protein-1.

9032571

Jacobs HS

1996

Polycystic ovary syndrome: the present position.

9037949

Fujii M

1996

Simultaneous intra- and extra-uterine pregnancy with ovarian hyperstimulation syndrome after induction of ovulation: a case report.

9050675

Rose BI

1996

Ovarian drilling in infertile women with polycystic ovary syndrome.

9050677

Adamson GD

1996

Polycystic ovary disease.

9050679

Merchant RN

1996

Treatment of polycystic ovary disease with laparoscopic low-watt bipolar electrocoagulation of the ovaries.

9050713

Pelosi MA

1996

Laparoscopic electrosurgical furrowing technique for the treatment of polycystic ovaries.

9057471

Azizlerli H

1997

Steroid cell tumor of the ovary as a rare cause of virilization.

9072506

Mar?n-Cant? VA

1997

[Participation of growth factors in human reproduction].

9074251

Tulandi T

1996

Reproductive Performance and Three-Dimension-Ultrasound Volume Determination of Polycystic Ovaries after Laparoscopic Ovarian Drilling

9080230

Cohen J

1996

Laparoscopic procedures for treatment of infertility related to polycystic ovarian syndrome.

9080676

Abhilasha

1997

Adiposity and androstenedione production in relation to delayed ovulation in the Indian bat, Scotophilus heathi.

9091329

van Santbrink EJ

1997

Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome.

9091330

Farhi J

1997

Early prediction of ovarian multifollicular response during ovulation induction in patients with polycystic ovary syndrome.

9091331

Genazzani AD

1997

A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome.

9091350

Allen SE

1997

Prevalence of hyperandrogenemia among nonhirsute oligo-ovulatory women.

9091357

Durmu?o?lu F

1997

Efficacy and safety of finasteride?

9093185

Najmabadi S

1997

The significance of polycystic-appearing ovaries versus normal-appearing ovaries in patients with polycystic ovary syndrome.

9096870

Duleba AJ

1997

Effects of insulin and insulin-like growth factors on proliferation of rat ovarian theca-interstitial cells.

9098468

Fi?icio?lu C

1995

The number of follicles and ovarian volume in the assessment of the response to clomiphene citrate in polycystic ovarian syndrome.

9100587

Ek I

1997

Impaired adipocyte lipolysis in nonobese women with the polycystic ovary syndrome: a possible link to insulin resistance?

9100625

Waterworth DM

1997

Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome.

9109850

Castelo-Branco C

1997

Gonadotropin-releasing hormone analog plus an oral contraceptive containing desogestrel in women with severe hirsutism: effects on hair, bone, and hormone profile after 1-year use.

9109854

Velazquez EM

1997

Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome.

9116775

Pauthier S

1997

[Endoscopic laser CO2 treatment of infertility due to polycystic ovarian syndrome].

9127132

I?ik AZ

1997

Endocrinological and clinical analysis of hyperprolactinemic patients with and without ultrasonically diagnosed polycystic ovarian changes.

9130733

Aci?n P

1997

Clinical and hormonal effects of the combination gonadotrophin-releasing hormone agonist plus oral contraceptive pills containing ethinyl-oestradiol (EE) and cyproterone acetate (CPA) versus the EE-CPA pill alone on polycystic ovarian disease-related hyperandrogenisms.

9130743

Sengoku K

1997

The chromosomal normality of unfertilized oocytes from patients with polycystic ovarian syndrome.

9130888

Porcu E

1997

Chronobiologic evolution of luteinizing hormone secretion in adolescence: developmental patterns and speculations on the onset of the polycystic ovary syndrome.

9130910

Fallat ME

1997

M?llerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis.

9130926

Miller WL

1997

Pathophysiology, genetics, and treatment of hyperandrogenism.

9133145

Nawroth F

1997

[Spontaneous pregnancy after laparoscopic salpingostomy and electrocoagulation of the ovarian surfaces in a patients with polycystic ovary syndrome].

9135691

Rittmaster RS

1997

Polycystic ovary syndrome, hyperthecosis and the menopause.

9135692

Techatraisak K

1997

Frequency of a polymorphism in the regulatory region of the 17 alpha-hydroxylase-17,20-lyase (CYP17) gene in hyperandrogenic states.

9135693

Franks S

1997

The 17 alpha-hydroxylase/17,20 lyase gene (CYP17) and polycystic ovary syndrome.

9135698

Gennarelli G

1997

The counterregulatory response to hypoglycaemia in women with the polycystic ovary syndrome.